Clinical Trials
10 trialsNCT02159066 2024-03-05
LOGIC-2
Pfizer
Phase 2 Completed
NCT02000882 2022-02-07
STAR Cape+BKM120 MBC With Brain Met
US Oncology Research
Phase 2 Completed
NCT01816594 2019-11-14
NeoPHOEBE
Novartis
Phase 2 Completed
NCT01289041 2019-05-30
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
Novartis
Phase 2 Completed
NCT01833169 2018-10-19
SIGNATURE
Novartis
Phase 2 Completed
NCT01693614 2018-09-28
Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
Novartis
Phase 2 Completed
NCT01923168 2018-09-14
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Novartis
Phase 2 Completed
NCT01852292 2018-07-24
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
Novartis
Phase 2 Terminated
NCT01613677 2017-04-20
Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer
Novartis
Phase 2 Withdrawn
NCT01297491 2016-03-11
BASALT-1
Novartis
Phase 2 Completed